Seventeen analogs of the repellent compounds N,N-diethyl-3-methylbenzamide (DEET) and N,N-diethylphenylacetamide (DEPA) were evaluated in vitro for repellency against laboratory-reared Aedes aegypti (L.) and Anopheles stephensi Liston mosquitoes by using a modified membrane blood feeding test system. The system was a valuable tool for comparing the effective concentrations of the repellent analogs. Additionally, this method used easily controlled test conditions, allowing completion of the many test replications necessary to evaluate all of the repellent analogs over a period of several years. One compound, N,N-diethyl-2-[3-(triflouromethyl)phenyl]acetamide, provided significantly better repellency than DEET against Ae. aegypti and slightly improved efficacy against An. stephensi. Eight of the analogs were as effective as or slightly more repellent than DEET against both species. Seven analogs were less effective than DEET and one compound, N,N-diethyl-3-hydroxybenzamide, was as a poor repellent. Overall, two DEPA analogs and a single DEET analog provided better repellency than DEET against both mosquito species and warrant future laboratory and field evaluation.
You have requested a machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Neither BioOne nor the owners and publishers of the content make, and they explicitly disclaim, any express or implied representations or warranties of any kind, including, without limitation, representations and warranties as to the functionality of the translation feature or the accuracy or completeness of the translations.
Translations are not retained in our system. Your use of this feature and the translations is subject to all use restrictions contained in the Terms and Conditions of Use of the BioOne website.